• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
INK128

INK128

Product ID I5440
Cas No. 1224844-38-5
Purity ≥99%
Product Unit SizeCostQuantityStock
1 mg $72.00 In stock
5 mg $135.10 In stock
25 mg $390.70 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

INK-128 is an ATP-competitive inhibitor of mTOR, inhibiting both mTORC1 and mTORC2, protein complexes that modulate cell growth, cell survival, and cell migration. This compound displays anticancer chemotherapeutic and anti-metastatic activities in both in vitro and in vivo models. In vitro, INK-128 inhibits cell migration and adhesion, processes critical for the invasive nature of multiple myeloma; INK-128 also inhibits proliferation and decreases colony formation in an in vitro model of B-cell acute lymphoblastic leukemia. In vivo, INK-128 decreased metastases in an animal model of prostate cancer. This compound is currently in clinical trials as a potential treatment for multiple myeloma.

Product Info

Cas No.

1224844-38-5

Purity

≥99%

Formula

C15H15N7O

Formula Wt.

309.33

Chemical Name

5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1, 3-benzoxazol-2-amine

IUPAC Name

5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1, 3-benzoxazol-2-amine

Synonym

MLN-0128, Sapanisertib

Solubility

DMSO 62 mg/mL (200.43 mM) Ethanol 2 mg/mL (6.46 mM) Water Insoluble

Appearance

pink powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

I5440 MSDS PDF

Info Sheet

I5440 Info Sheet PDF

Brochures

PI3K-Akt-mTORC Pathway Booklet

References

Janes MR, Vu C, Mallya S, et al. Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia. 2013 Mar;27(3):586-94. PMID: 23090679.

Hsieh AC, Liu Y, Edlind MP, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012 Feb 22;485(7396):55-61. PMID: 22367541.

Maiso P, Liu Y, Morgan B, et al. Defining the role of TORC1/2 in multiple myeloma. Blood. 2011 Dec 22;118(26):6860-70. PMID: 22045983.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • K0552

    Kb NB 77-78

    CID-797718 analog; potential PKD1 binding agent...

    ≥98%
  • C2900

    CH5424802

    ALK inhibitor.

    ≥99%
  • T0102

    7-epi-Taxol

    Taxane found in Taxus; potential microtubule de...

    ≥95%
  • B8278

    Butoconazole Nitrate

    Imidazole; 14-α demethylase inhibitor.

    ≥98%
  • L960006

    LY-2606368

    CHK1 inhibitor.

    ≥98%
  • I8618

    Ivermectin

    Avermectin; glu-gated Cl- channel activator, Gl...

    ≥95%
  • M1746

    Melphalan

    Nitrogen mustard, DNA alkylator.

    ≥95%
  • T1644

    Telmisartan

    AT-II antagonist, PPARγ/δ modulator.

    ≥98%
  • O9257

    16-Oxokahweol

    Synthetic kahweol derivative.

    ≥95%
  • M4000

    MK-2206 Monohydrochloride

    Akt inhibitor.

    ≥99%
  • Z3463

    Ziprasidone

    5-HT1A agonist, D2, 5-HT1D antagonist.

    ≥98%
  • P577520

    Ponatinib

    pan-Bcr-Abl tyrosine kinase inhibitor.

    ≥99%
  • L9610

    Lycorine Hydrochloride

    Alkaloid found in plants in the Amaryllidaceae ...

    ≥98%
  • N3478

    Nitrendipine

    Calcium channel blocker.

    ≥98%
  • A4802

    Amantadine Hydrochloride

    Viral M2 proton channel blocker, MAO-A, NET, NM...

    ≥98%
  • E6995

    Erythromycin Ethylsuccinate

    Macrolide; protein translation inhibitor, mamma...

    ≥97%
  • T2816

    L-Theanine

    Non-essential amino acid found in Camellia and ...

    ≥98%
  • M5756

    Montelukast Sodium

    CysLT1 antagonist.

    ≥98%
  • C4756

    Cloxacillin Sodium Monohydrate

    β-lactam; penicillin binding protein inhibitor...

    ≥98%
  • Z160021

    Zearalanone

    Mycotoxin.

    ≥97%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only